* acute illness with fever * prior documented infection with sars-cov-2 * triple anticoagulation therapy * subject is currently enrolled in or has not yet completed at least 30 days since ending other investigational device or drug trial(s), or subject is receiving other investigational agent(s) * subject has known sensitivity or intolerance to any of the products to be administered for the purpose of this study * subject has any kind of disorder that compromises the ability of the subject to give written informed consent and/or to comply with the study procedures * subject is pregnant or breast feeding

* acute illness with fever * prior documented infection with sars-cov-2 * triple anticoagulation therapy * subject is currently enrolled in or has not yet completed at least 30 days since ending other investigational device or drug trial(s), or subject is receiving other investigational agent(s) * subject has known sensitivity or intolerance to any of the products to be administered for the purpose of this study * subject has any kind of disorder that compromises the ability of the subject to give written informed consent and/or to comply with the study procedures * subject is pregnant or breast feeding

acute illness with fever prior documented infection with sars-cov-2 triple anticoagulation therapy subject is currently enrolled in or has not yet completed at least 30 days since ending other investigational device or drug trial(s), or subject is receiving other investigational agent(s) subject has known sensitivity or intolerance to any of the products to be administered for the purpose of this study subject has any kind of disorder that compromises the ability of the subject to give written informed consent and/or to comply with the study procedures subject is pregnant or breast feeding

acute illness with fever prior documented infection with sars-cov-2 triple anticoagulation therapy subject is currently enrolled in or has not yet completed at least 30 days since ending other investigational device or drug trial(s), or subject is receiving other investigational agent(s) subject has known sensitivity or intolerance to any of the products to be administered for the purpose of this study subject has any kind of disorder that compromises the ability of the subject to give written informed consent and/or to comply with the study procedures subject is pregnant or breast feeding